Skip to content

Clinical outcome of treatment in non-small cell lung cancer patients with positive driver genes after radical resection: a multicenter, observational clinical study

Clinical outcome of treatment in non-small cell lung cancer patients with positive driver genes after radical resection: a multicenter, observational clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057035
Enrollment
Unknown
Registered
2022-02-26
Start date
2022-02-26
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer (NSCLC)

Interventions

case series:None

Sponsors

Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years; 2. Patients with stage I-IIIA and part of stgage IIIB (T3-4N2MO) NSCLC will be included in the study; 3. Patients with positive lung cancer driver genes (EGFR, ALK, ROS1, etc.); 4. Patients proposed to receive radical resection; 5. Patients have normal reading and writing skills with sound cognitive and behavioral abilities; 6. Patients voluntarily participate in the study and sign a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe complications after radical resection of non-small cell lung cancer that affect postoperative treatment; 2. Patients participating in clinical studies of any other drug; 3. Patients who cannot cooperate, have cognitive impairment, and have no complete behavioral capacity; 4. Patients who do not want to join the study.

Design outcomes

Primary

MeasureTime frame
Disease-free survival ;Overall suivival;

Countries

China

Contacts

Public ContactJiang Liyan
jiang_liyan2000@126.com+86 13916146759

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026